Prostate cancer is often first identified on screening due to widespread implementation of prostate-specific antigen (PSA)-based screening, and trans-rectal ultrasound (TRUS) guided tissue-biopsies are used to confirm diagnoses [4]. The gene discussed is KLK3; the disease is prostate carcinoma.